INDICATION:  It is used to reduce LDL-cholesterol, Apolipoprotein B, and triglycerides, and to increase HDL-cholesterol in the treatment of hyperlipidaemias, including hypercholesterolaemias and combined (mixed) hyperlipidaemia (Type Ila or llb hyperlipoproteinaemias), hypertriglyceridaemia (Type IV), and dysbetalipoproteinaemia (Type III) and also can be effective as adjunct therapy in patients with homozygous familial hypercholesterolaemia who have some LDL receptor function.

CONTRAINDICATIONS: Hypersensitivity to Atorvastatin, active liver disease or unexplained persistent elevations of serum transaminases exceeding three times the upper limit of normal. 

ADR REPORTING STATEMENT: "For suspected adverse drug reaction, report to the FDA: www.fda.gov.ph." Seek medical attention immediately at the first sign of any adverse drug reaction.